OMICS International

International Conferences

Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series Ltd: World’s leading Event Organizer

 

Pulmonary Disease


As per available reports about 10Relevant journals,14Conferences,11Workshops are presently dedicated exclusively to breathing disorder and about 268 articles are being published on pulmonary disease.

Pulmonary disease is a lung condition usually caused by smoking that makes it hard to breathe. It is caused by damage to the lungs over many years. Over time, breathing tobacco smoke irritates the airways and destroys the stretchy fibers in the lungs. It affects more than 24 million people in the U.K, or 6 percent of the population. It is the third leading cause of death in the U.K. Other things that may put you at risk include breathing chemical fumes, dust, or air pollution over a long period of time. Secondhand smoke also may damage the lungs. The main symptoms are: A long-lasting (chronic) cough, Mucus that comes up when you cough, Shortness of breath that gets worse when you exercise and excessive sputum production. However, COPD is not just simply a "smoker's cough", but a under-diagnosed, life threatening lung disease that may progressively lead to death. Less common symptoms include anxiety, arm and shoulder pain, and tenderness in the calf of the leg, erythema nodosum, swelling of the face, headache, hoarseness, joint pain, and somnolence.

OMICS International Organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide. 

Scope and Importance:

Pulmonary Disease focusing on concise rapid reporting of clinical studies and reviews in pulmonary disease. Special focus will be given to the pathophysiological processes underlying the disease, intervention programs, patient focused education, and self-management protocols. This journal is directed at specialists and healthcare professionals. Pulmonary disease may lead to various complications such as respiratory failure, right heart failure or cor pulmonale, polyglobulia, and late in the course of the disease, pulmonary hypertension. The course of pulmonary disease is complicated by acute exacerbations that occur with increasing frequency as disease progresses. Pulmonary disease is also associated with extra pulmonary affects. The prevalence of coronary arterial diseases is significantly higher among pulmonary patients compared with individuals of the same age and sex (22% vs. 14.5%). This is also true for cardiac failure (13.5% vs. 2.5%) or neurologic disease (14% vs. 3.5%).

Pulmonary disease is a lung condition usually caused by smoking that makes it hard to breathe. It is caused by damage to the lungs over many years. Over time, breathing tobacco smoke irritates the airways and destroys the stretchy fibers in the lungs. It affects more than 24 million people in the U.S., or 6 percent of the population. It is the third leading cause of death in the U.S. Other things that may put you at risk include breathing chemical fumes, dust, or air pollution over a long period of time. Secondhand smoke also may damage the lungs. The main symptoms are: A long-lasting (chronic) cough, Mucus that comes up when you cough, Shortness of breath that gets worse when you exercise and excessive sputum production. However, COPD is not just simply a "smoker's cough", but a under-diagnosed, life threatening lung disease that may progressively lead to death. Less common symptoms include anxiety, arm and shoulder pain, and tenderness in the calf of the leg, erythema nodosum, swelling of the face, headache, hoarseness, joint pain, and somnolence. Diagnostic procedures for pulmonary diseases include bronchoscopy, cytologic, serologic, and biochemical examination of bronchial secretions; laryngoscopy; pulmonary function tests; and radiography. 

Market Analysis:

The United Kingdom respiratory care market, Based on anatomical features, the respiratory system is segmented into upper respiratory tract and lower respiratory tract. The upper respiratory tract comprises pharynx, larynx, and nasal passages, while the lower respiratory tract includes trachea, lungs, and bronchi. Respiratory disease is a medical condition that affects the structure and organs associated with respiration or breathing. Equipment used to detect pulmonary abnormalities hold immense potential due to increasing prevalence of various respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, and pneumonia. Moreover, growing geriatric population and technological advancements would drive the global respiratory disease testing market. However, low adoption rate of digital radiography and portable spirometers are projected to hold back the growth of respiratory disease testing market from 2014 to 2022. The global respiratory disease testing market was valued at USD 2,326.5 million in 2013 and is estimated to reach USD 3,143.3 million in 2022, expanding at a CAGR of 3.4% from 2014 to 2022. For instance, the Centers for Disease Control and Prevention (CDC) published in 2012 that around 18.7 million adults in the U.K. were suffering from asthma. The American Lung Association states that COPD is the third leading cause of death in the U.K.

List of Conferences:

3rd Rhinology and Otology Conference <br>April 25-27, 2016 Dubai, UAE

4th Bacteriology and Infectious Diseases Conference <br>May 16-18, 2016 San Antonio, USA

2nd Respiratory and Pulmonary Medicine Conference <br>May 09-10, 2016 Chicago, USA

3rd COPD conference <br>July 11-12, 2016 Brisbane, Australia  

2nd Infectious Diseases Conference: <br>August 25-27, 2016 Philadelphia, USA

Global Influenza Conferences <br>August 24-26, 2015 West Drayton, London, UK  

4th Lung and Respiratory Care Conference <br>Aug-1-3, 2016 Manchester, UK

4th Immunology Conference <br>September 28-30, 2015 Houston, Texas, USA

 Infectious Diseases and Diagnostic Microbiology Conference <br>Oct 3-5, 2016 Vancouver, Canada

2nd Flu Conference <br>November 17-19, 2016 San Francisco, USA

Indian Chest Society and Chest Physicians 17th Joint National Conference
November 4-7, 2015, Jaipur, India.

11th Respiratory Diseases conference
October 8-11, 2015, Chengdu, India

CHEST 2015 Conference:
October 24-28, Canada

46th Lung Health Conference, Cape Town, South Africa,
Dec: 2-6, 2015

20th Congress of the Asia Pacific Society of Respirology, Malaysia,
Dec-2-3, 2015

5th TB and Lung Disease Conference - Asia Pacific Region:
Aug-31, Sep- 2, 2015, Sydney

Respiratory Pathogens Conference:
Sep 2-4, 2015, Singapore

Respiratory Diseases Conference:
Sep3-6, Guiyang City

Respiratory Care Indonesia:
Sep2-4, Shangri-La Hotel

16th Lung Cancer Conference:
September 6 - 9 2015 Colorado, USA

European Respiratory Society International Congress:
26 September 2015, Amsterdam 

 Relevant Societies and Associations:

Cambridge Development Initiative

Cambridge Graduate Course in Medicine Society

Cambridge Romanian Society

Research Drones Society, Oxford

Midland Geotechnical Society – UK

Palaeontological Association – UK

The British Hospitality Association

National Housing Federation

Self-Storage Association UK

Vietnam Respiratory Society  

Lung Health UK

British Lung Foundation

British Thoracic Society

British Association for Lung Research

The Sarcoidosis charity

The Freeman Heart & Lung Transplant Association

British Snoring and Sleep Apnoea Association

Association of Respiratory Nurses (ARNS)

Association of charted Physiotherapists in respiratory care (ACPRC)

List of Companies and retreat centers:

GlaxoSmithKline

 Pfizer

 Sanofi-Aventis

 AstraZeneca

 Novartis

Roche

 Wyeth

 Merk & Co

 Lilly

 Boehringer Ingelheim

 Johnson & Johnson

 Schering Plough

 Novo Nordisk

 Bayer Schering

 Abbott

 Teva

 Bristol-Myers Squibb

 Mundi Int

 Gilead Sciences

Servier

Edwards Lifesciences

British American Tobacco

Imperial Tobacco Group

Reckitt Benckiser Group

Acm Global Central Laboratory Services Ltd

Acorn Polymers (U K ) Ltd

Access Health Products

Acm Global Central Laboratory Services Ltd

Acorn Equipment Co Ltd

Advanced Healthcare Ltd 

This page will be updated regularly.

This page was last updated on 14th Sep, 2015

Conferenceseries Destinations

Contact Us

Medical Conferences
Jessie Grace
jessie.grace@conferenceseries.com
1-702-508-5200 Ext:8031, 8041

Pharmaceutical Conferences
Badoni Victor
badoni.victor@conferenceseries.com
1-702-508-5200 Ext:8045, 8047

Immunology & Microbiology Conferences
Walker Smith
walker.smith@conferenceseries.com
1-702-508-5200 Ext:8031

Cancer Conferences
Raul Cliff
raul.cliff@conferenceseries.com
1-702-508-5200 Ext:8039

Nursing and Healthcare Conferences
Jennifer Leny
jennifer.leny@conferenceseries.com
1-702-508-5200 Ext:8044

Diabetes Conferences
Stanley knight
stanley.knight@conferenceseries.com
1-702-508-5200 Ext:8040

Neuroscience Conferences
Sandeep Kumar
sandeep@conferenceseries.com
1-702-508-5200 Ext:8034

Dental Conferences
Raul Cliff
raul.cliff@conferenceseries.com
1-702-508-5200 Ext:8039

Clinical and Biochemistry Conferences
Rohit Casper
rohit.casper@conferenceseries.com
1-702-508-5200 Ext:8033

Biotechnology Conferences
Ravi Vittal
ravi.vittal@conferenceseries.com
1-702-508-5200 Ext:8031, 8037

Material Science Conferences
Lucy Grey
lucygrey@conferenceseries.com
1-702-508-5200 Ext:8035

Genetics & Mol Biology Conferences
Stephen Bruce
stephen.bruce@conferenceseries.com
1-702-508-5200 Ext:8038

Engineering Conferences
Dolly A
dolly@conferenceseries.com
+1-702-508-5200 Ext:8051

Program Enquiries
Symposia/Workshops
Sponsorships
Media Partners | Advertising